Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,788,000
-
Share change
-
-4,033,351
-
Total reported value
-
$14,637,934
-
Price per share
-
$0.70
-
Number of holders
-
64
-
Value change
-
-$3,018,818
-
Number of buys
-
23
-
Number of sells
-
48
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q2 2023
As of 30 Jun 2023,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,788,000 shares.
The largest 10 holders included
AMERIPRISE FINANCIAL INC, 683 Capital Management, LLC, VANGUARD GROUP INC, Simplify Asset Management Inc., BlackRock Inc., UBS OCONNOR LLC, RBF Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and GSA CAPITAL PARTNERS LLP.
This page lists
64
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.